Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCAHCardinal Health
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | CAH | TMO |
|---|
| Close | 250.48 | 697.00 |
| Market Cap | $58.8B | $258B |
| 1M | +12.58% | +3.25% |
| P/E (TTM) | 34.2 | 36.4 |
| Forward P/E | 17.3 | 24.6 |
| P/E 5-Yr Percentile | 38 | 78 |
| P/S | 0.2 | 5.4 |
| P/B | 58.8 | 4.7 |
| Dividend Yield | 1.88% | 0.29% |
| Latest Quarter Revenue | $64.5B | $12.1B |
| Revenue YoY | +7.1% | +9.1% |
| Gross Margin | 4.4% | — |
| Latest Quarter EPS | — | 4.64 |
| Avg Post-Earnings Move | ±1.4% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.92% | 1.82% |
| 90-Day Net Insider Buying | −$59.6M | −$40.3M |
CAH · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
